can semaglutide make you gassy Top 5 Common Side Effects and How to Minimize Them How Does Wegovy (Semaglutide) Work?

When to Consider Alternative GLP-1 Options or Next Steps If semaglutide plateau persists despite dose optimization and behavioral changes, switching to tirzepatide is evidence-supported

Our approach combines advanced medical science with modern technology to create tailored weight loss programs that respect each individual's unique journey

Key clinical considerations for using onceweekly subcutaneous semaglutide 2.4 mg in clinical practice Currently, onceweekly subcutaneous semaglutide 2.4 mg is approved for use in Canada, Europe, the UK and the USA as an adjunct to a reduced calorie diet and increased physical activity for chronic weight management in adults with an initial BMI of 30 or 27 kg/m 2 in the presence of 1 weightrelated comorbid condition

While both ShedRx and Remedy Meds offer pathways to access GLP-1s, Remedy Meds currently provides a more transparent, user-friendly option

Aspen has a marketing agreement with Eli Lilly for the sale and distribution of tirzepatide in sub-Saharan Africa and announced the launch of Mounjaro in South Africa in December 2024